
Rablax D 30mg/20mg Capsule SR
Marketer
Med Lex Pharmaceutical
Salt Composition
Domperidone (30mg) + Rabeprazole (20mg)
Overview Rablax D 30mg/20mg Capsule SR
Gastro-esophageal reflux disease (GERD) is effectively managed with the combined-action capsules, Rablax D SR (30mg/20mg). This medication targets acid reflux symptoms such as heartburn, abdominal pain, and irritation by neutralizing stomach acid and facilitating gas expulsion for enhanced comfort. Administer Rablax D SR as prescribed, taking it on an empty stomach. Dosage and treatment duration depend on individual response and should adhere to your physician's instructions. Premature cessation may lead to symptom recurrence and condition exacerbation. Disclose all concurrent medications to your doctor as interactions are possible. Common, generally transient side effects include diarrhea, abdominal discomfort, dry mouth, headache, flatulence, and fatigue. Report any concerning side effects promptly. Drowsiness and dizziness are potential effects; avoid driving or activities requiring alertness until the medication's impact is assessed. Alcohol consumption should be avoided due to potential drowsiness exacerbation. Lifestyle adjustments, such as consuming cold milk and avoiding caffeinated beverages, spicy foods, and chocolate, can improve outcomes. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, and disclose pregnancy, pregnancy plans, or breastfeeding.
Primary Ingredients of Rablax D 30mg/20mg Capsule SR
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Rablax D 30mg/20mg Capsule SR
Managing gastroesophageal reflux and peptic ulcers.
Major Benefits of Rablax D 30mg/20mg Capsule SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire capsule without chewing, crushing, or breaking it. Rablax D 30mg/20mg sustained-release capsules should be taken on an empty stomach.
Common Side effects of Rablax D 30mg/20mg Capsule SR:
- Cough
- Headache
- Diarrhea
- Dizziness
- Inflammation of the nose
- Abdominal pain
- Vomiting
- Weakness
- Nasal congestion (stuffy nose)
- Insomnia (difficulty in sleeping)
- Fundic gland polyps
- Nausea
- Constipation
- Flatulence
- Back pain
- Pharyngitis
How to use Rablax D 30mg/20mg Capsule SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the capsule whole; avoid chewing, crushing, or fracturing it. Rablax D 30mg/20mg Sustained-Release Capsules should be taken on an empty stomach.
How Rablax D 30mg/20mg Capsule SR works:
Rablax D SR capsules (30mg/20mg Domperidone/Rabeprazole) combine a prokinetic agent, Domperidone, with the proton pump inhibitor (PPI), Rabeprazole. Domperidone enhances upper gastrointestinal motility, facilitating smoother food passage. Rabeprazole decreases stomach acid production, providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Rablax D 30mg/20mg Capsule SR concurrently with alcohol. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Rablax D 30mg/20mg sustained-release capsules during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Rablax D 30mg/20mg capsules are likely unsafe for breastfeeding mothers. Available human evidence indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking Rablax D 30mg/20mg sustained-release capsules may cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Exercise caution when administering Rablax D 30mg/20mg sustained-release capsules to individuals with renal impairment; dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should exercise caution when using Rablax D 30mg/20mg SR capsules; dosage modification may be necessary. Consult a physician. Rablax D 30mg/20mg SR capsules are contraindicated for individuals with moderate to severe hepatic dysfunction.
What if you forget to take Rablax D 30mg/20mg Capsule SR :
Should you forget a dose of Rablax D 30mg/20mg sustained-release capsules, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Rablax D 30mg/20mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
